Aussie Doctors Complain High Prices Limit Cancer Patient Drug Access
This article was originally published in PharmAsia News
Executive Summary
Australia cancer physicians are challenging the drug industry's high prices blamed for undermining the ability of any but the wealthy to afford treatment.